Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-24, Stock:LLY, The news for the past five days is as follows:
2019-10-17: NEWS1: Lilly's Pancreatic Cancer Candidate Fails in Phase III Study.NEWS2: Can New Drugs Help Lilly (LLY) to Deliver Solid Q3 Earnings?.NEWS3: 4 Biotech Stocks That Are Set to Rally, Analyst Says.
2019-10-18: NEWS1: New Gilead CFO: Let's Make a Deal.NEWS2: Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow.
2019-10-21: NEWS1: Lilly Declares Fourth-Quarter 2019 Dividend.
2019-10-22: NEWS1: [video]Eli Lilly Expected to Earn $1.40 a Share.NEWS2: 2 Large-Cap Stocks Announce Dividends.NEWS3: Drug/Biotech Stock Q3 Earnings on Oct 23: LLY, ALXN & More.NEWS4: Beware Biogen’s Alzheimer’s Drug Resurrection.NEWS5: Eli Lilly Reports Earnings Tomorrow. Here’s What to Expect..
2019-10-23: NEWS1: Two Drugmakers Beat Earnings Forecasts — So Why Did One Topple?.NEWS2: Boeing, Caterpillar report disappointing earnings, but their shares bounce back.NEWS3: Two Drugmakers Beat Earnings Forecasts — So Why Did One Topple?.NEWS4: Eli Lilly to target cancer drug developers for deals.NEWS5: Lilly (LLY) Q3 Earnings Top Estimates, Sales Lag, Stock Down.NEWS6: Eli Lilly Earned More Than Expected. Here’s Why the Stock Is Falling Anyway..NEWS7: Eli Lilly (LLY) Surpasses Q3 Earnings Estimates.NEWS8: Eli Lilly Reports Mixed Q3 Earnings, Raises Guidance.NEWS9: Eli Lilly, Alexion Earnings Top Q3 Views, But Stocks Diverge.NEWS10: Eli Lilly raises earnings guidance as new drugs boost sales.NEWS11: Eli Lilly tops profit estimates in latest quarter as revenue falls short.NEWS12: UPDATE 4-Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop.NEWS13: Sales of Eli Lilly diabetes drug Trulicity fall short, shares drop.NEWS14: Eli Lilly reports 9% rise in third-quarter profit.NEWS15: Eli Lilly misses sales estimates as top-seller Trulicity disappoints.NEWS16: Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance.NEWS17: Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno.NEWS18: Eli Lilly Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance.NEWS19: Stocks - Caterpillar, Eli Lilly, Texas Instruments Fall Premarket; Boeing Rises.

Answer: Rise